ATTENTION:
For security reason, please registered here under
before
Tuesday 18th March at noon.
Attendance is free but registration is mandatory for
everyone, included people working at CERN.
Live webcast of the whole event:
www.cern.ch/video click on "live"
Programme
17h00-19h00
conference
19h00-21h00
networking & cocktail offered by
l'Agence de Développement Economique du Pays de Gex et
Bellegarde
Introduction
European intergovernmental research laboratories such as
CERN, the European Space Agency, ESA, and the European
Molecular Biology Laboratory, EMBL, are major sources of
innovative technologies, and transfer these technologies
to industry throughout Europe. In the last few years,
several of these laboratories have adopted innovative
strategies in the area of industrial partnership and
technology spin-off. This First Tuesday will provide a
snapshot of the latest trends: the European Space
Incubator being established at ESA; the company EMBLEM
which has been created to market innovation from EMBL; a
Partnership for Structural Biology coordinated by the
European Synchrotron Radiation Facility involving biotech
and pharma companies as well as other research labs; the
CERN openlab for DataGrid applications, a partnership
with leaders in the IT industry.
Panel organized
and chaired by
François Grey,
Francois.Grey@cern.ch
CERN openlab development,
www.cern.ch/openlab
with
Pierre
Brisson,
pierre.brisson@esa.int
Head of Technology Transfer and Promotion Office,
European Space Agency, ESA,
www.esa.int/technology
“The European Space Incubator at ESA”
To bridge the gap between idea and actual business, the
European Space Incubator (ESI) and its associated
network, ESINET, are designed to get space
technology-related projects off the ground and help them
develop into viable businesses. ESI will be located in
Noordwijk (the Netherlands) near ESTEC, the technical
centre of ESA. ESI will provide operational services and
know-how in a state-of-the-art technical environment.
Dr. Pierre Brisson has a PhD in Physics from the
University of Rennes and a Doctorate in Electronics
Engineering from the University of Clermont-Ferrand in
France and Houston in the United States. He has worked at
the
French Space Agency CNES as a scientist. He has also
worked for a number of years in industry for a company in
the south of France that makes semiconductors. His
present job at ESA is Head of the Technology Transfer and
Promotion Office. This office is responsible for finding
and promoting non-space applications for technology
originally developed for space.
Gabor Lamm,
lamm@embl-em.de
Managing Director, European Molecular Biology Laboratory,
EMBLEM Technology Transfer GmbH,
www.embl-em.de
“EMBL Enterprise Management: Innovation Works“
The talk will describe the components in place at the
European Molecular Biology Laboratory (EMBL) which
provide an efficient and professional technology transfer
process.
EMBL Enterprise Management Technology Transfer GmbH
(EMBLEM
http://www.embl-em.de) is a subsidiary and the
commercial arm of the EMBL. EMBLEM, established in 1999
identifies, protects and commercialises the intellectual
property developed in the EMBL-world, from EMBL-alumni
and from non-EMBL third parties. The EMBL Technology Fund
(ETF
http://www.embl-ventures.com) is a true early stage
venture capital fund with a current fund volume of over
25 million EURO provided by renowned institutional and
private investors in Europe including EMBLEM. The
investment focus of the ETF is life-science companies in
Europe spanning diagnostics, bioinformatics, target
validation and drug design to technology platforms,
medical devices, therapeutics and theranostics.
Dr. Gabor Lamm is a graduate of Edinburgh University
(Biochemistry) and holds a Ph.D. in Molecular Biology.
After spending three years as a research scientist at the
Boehringer Ingelheim Institute of Molecular Pathology
(IMP) in Vienna, Dr. Lamm has been Business-Team Leader
at Wacker Chemie in the division specialising in advanced
ceramic components for high-tech applications. As of
October 2000 he became Managing Director of EMBLEM.
Edward Mitchell,
mitchell@esrf.fr
Coordinator of the PSB, ESRF,
psb.esrf.fr
“The Partnership for Structural Biology”
Starting in 2003, four leading European research
institutes join forces and combine their skills to create
a Centre of Excellence for Structural Biology. The
partners are the European Synchrotron Radiation Facility,
ESRF, the European Molecular Biology Laboratory, EMBL,
The Institut Laue Langevin, ILL, and the Institut de
Biologie Structurale, IBS. Aside from the four founding
Partners, the PSB is enthusiastic to involve industrial
and other interested European academic parties in its
initiative. Individual companies, both established
pharmaceutical enterprises and promising start-up
biotechnology companies, are being invited to become
Associate Members of the PSB and contribute to the
activities and developments
Dr. Edward Mitchell is currently employed by ESRF, and is
responsible for building a new beamline that is part of
the ESRF’s contribution to the Partnership for Structural
Biology. Dr. Mitchell has been at the ESRF for seven
years, and was previously at Oxford University, where he
obtained a Ph.D. in molecular biophysics.
Wolfgang von Rüden,
Wolfgang.von.Rueden@cern.ch
Leader of Information Technology Division, and Head of
CERN openlab,
www.cern.ch/openlab
”The CERN openlab for DataGrid applications”
In 2002, HP joined Intel and Enterasys
Networks in the CERN openlab for DataGrid applications.
This partnership has launched an ambitious project called
CERN opencluster, which combines cutting edge
technologies from the industrial partners. The
partnership allows CERN to peer into the technological
crystal ball and test technologies that may well be
commercially competitive when the Large Hadron Collider (LHC)
is up and running. The industrial partners are able to
develop and test new technologies, which are still far
from the market, under the rigorous and demanding
conditions that CERN's advanced computing environment
provides. In particular, the CERN opencluster will be
linked to the European Data Grid testbed, to see how
these new technologies perform in a Grid environment. The
CERN openlab concept has proved very popular, with other
major computer and software manufacturers eager to join.
Dr. Wolfgang von Rüden obtained a Ph.D. in Physics from
Mainz University for experimental work carried out at.
From 1981 he was coordinator of the data acquisition
project on Aleph, one of the LEP experiments. In 1990 he
became co-founder and first CEO of a start-up, Ibex
Computing, based at the international business park in
Archamps. From 1994 to 1998 he was Technical Director of
GSI, a heavy ion research centre in Darmstadt. Returning
to CERN in 1998 he became group leader of the physics
data processing group, was appointed Deputy Division
Leader of Information Technology in 2001 and Division
Leader as of 2003.
Elevator pitches (3 min. each) before the panel with:
Stefano Buono,
stefano.buono@adacap.com
President Directeur Général, Advanced Accelerator
Applications,
www.adacap.com
"Radiopharmaceuticals Products as a Spin-off from CERN"
Advanced Accelerator Applications (AAA) activity adresses
demand from the increasing number of applications of
particle accelerators in the medical, industrial and
energy sectors. AAA initial commercial focus is the
medical diagnostic radioisotopes market (Positron
Emission Tomography consumables) in Italy, France and
Switzerland. A production facility in St. Genis'
technoparc (France) will be operational end of 2003. AAA
R&D focus is the medical therapy radioisotopes market
through the exploitation of a worldwide patent developed
at CERN by Nobel laureate Carlo Rubbia and his team,
which included Stefano Buono.
Denis Linglin,,
dlinglin@cc-pays-de-gex.fr
Vice-Président
chargé du développement économique, de l’emploi et de la
formation, Communauté de communes du Pays de Gex,
www.cc-pays-de-gex.fr
“Proposal for an incubator dedicated to CERN
technologies”
As part of a
national planning initiative in France, the Agence de
Développement Economique of the regions of Pays de Gex
and Bellegarde has identified CERN as a potential source
of technologies for a dedicated incubator, which would
help boost economic activity in the region. The incubator
should be truly European in scope, reflecting CERN’s
European status. In accordance with regional policy,
leading regional incubators with established track
records would be partners. A proposal for such an
incubator is now being prepared, and discussions with
Swiss counterparts concerning Swiss collaboration on this
project are also underway.
Carlo Wyss,
Carlo.Wyss@cern.ch
Director of Accelerators, CERN,
www.cern.ch
“The CERN Globe of Innovation”
CERN would like to share a unique opportunity with
partners in industry, commerce and the public sector. By
sponsoring the CERN Globe of Innovation project, partners
will take part in developing a stunning landmark
dedicated to basic research and innovation. The project
involves relocating to a site next to CERN the wooden
globe structure from Expo '02. The project also involves
the adjacent construction of the future control center of
the Large Hadron Collider, providing visitors with a
glimpse of the nerve center of the biggest physics
experiment on Earth. The Globe will have a modular public
exhibition space, allowing for planetarium-type
projections. Partners will have opportunities to use and
exhibit in these facilities.
Q&A,
followed by 2 hours networking from 19h00 to 21h00
